Basket Total: £0.00
Defence, Security, Energy, Utilities, Finance, Pharmaceuticals
Home > Pharmaceuticals > UK

Biobanking

24th June to 25th June 2013, London, United Kingdom
ConferenceBook NowProgrammeSpeakersSponsorsPartnersWorkshopVenueRelated Events

Overview

Open/Close

Integrating biobank systems with improved communication networks and global standardisation is essential as it has been projected that there will be approximately 200 biobanks operating across Europe alone in 2013. As researchers endeavour to develop more personalised medicines, acquiring high quality biospecimens is essential. This is reflected in the estimation that the global Biobanking market is expected to reach $183 billion in the next 5 years as biobanks experience rapid growth. SMi’s 3rd Annual Biobanking conference will aim to bring together key solution providers and potential clients affiliated with pharmaceutical companies and Biobanking institutions alike therefore providing an excellent platform for communication within the biobanking community.

SMi’s 3rd annual Biobanking event will reflect the significant change driving current development in biosample management and there will be efforts to link value to existing biological resources and coverage of important issues experienced by those who donate, manage and expend biobank samples. Focussing on the properties of data sharing and greater involvement between biobanks, allow Biobanking 2013 to give you the most up to date and relevant information on Biobanking today.

 

Comments from last years delegates included:

‘‘Entertaining and informative’’ – Roche
‘‘Stimulated, good discussions and provided good feedback on questions’’ – Merck
‘‘Interesting insight into an ethical/legal problem’’ – NIBSC
‘‘Detailed and specific’’ – GSK
‘‘Excellent insight!’’ – IRIS

 

Benefits of Attending

Open/Close

Featured Speakers

Open/Close

Who Should Attend

Open/Close
World Courier